1.
|
BB AggarwalA BhardwjRS AggarwalNP SeeramS
ShishodiaY TakadaRole of resveratrol in prevention and therapy of
cancer: preclinical and clinical studiesAnticancer
Res2427832840200415517885
|
2.
|
JK KunduKS ChunSO KimYJ SurhResveratrol
inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse
skin: MAPKs and AP-1 as potential molecular
targetsBiofactors2l3339200410.1002/biof.55221010815630167
|
3.
|
MH AzizR KumarN AhmadCancer
chemoprevention by resveratrol in vitro and in vivo studies and the
underlying mechanisms (review)Int J Oncol231728200312792772
|
4.
|
H JiangU ZhangJ KuoResveratrol-induced
apoptotic death in human U251 glioma cellsMol Cancer
Ther4554561200510.1158/1535-7163.MCT-04-005615827328
|
5.
|
TT WangNW SchoeneEK KimYS KimPleiotropic
effects of the sirtuin inhibitor sirtinol involves
concentration-dependent modulation of multiple nuclear
receptor-mediated pathways in androgen-responsive prostate cancer
cell LNCaPMol CarcinogApr112012(Epub ahead of
print)10.1002/mc.21906
|
6.
|
ME JuanI AlfarasJM PlanasColorectal cancer
chemoprevention by trans-resveratrolPharmacol
Res65584591201210.1016/j.phrs.2012.03.01022465196
|
7.
|
P LiuX WangC HuT HuInhibition of
proliferation and induction of apoptosis by trimethoxyl stilbene
(TMS) in a lung cancer cell lineAsian Pac J Cancer
Prev1222632269201122296367
|
8.
|
JH ZhouHY ChengZQ YuResveratrol induces
apoptosis in pancreatic cancer cellsChin Med J
(Engl)12416951699201121740780
|
9.
|
HB YuHF ZhangX ZhangResveratrol inhibits
VEGF expression of human hepatocellular carcinoma cells through a
NF-kappa B-mediated
mechanismHepatogastroenterology5712411246201021410066
|
10.
|
Y LiCM BäckesjöLA HaldosénU
LindgrenResveratrol inhibits proliferation and promotes apoptosis
of osteosarcoma cellsEur J
Pharmacol6091318200910.1016/j.ejphar.2009.03.00419285066
|
11.
|
HF DvorakLF BrownM DetmarAM DvorakVascular
permeability factor/vascular endothelial growth factor,
microvascular hyperpermeability, and angiogenesisAm J
Pathol1461029103919957538264
|
12.
|
G RanieriR PatrunoE RuggieriS MontemurroP
ValerioD RibattiVascular endothelial growth factor (VEGF) as a
target of bevacizumab in cancer: from the biology to the clinicCurr
Med Chem1318451857200610.2174/09298670677758505916842197
|
13.
|
LC BakerJK BoultS Walker-SamuelThe
HIF-pathway inhibitor NSC-134754 induces metabolic changes and
anti-tumour activity while maintaining vascular functionBr J
Cancer10616381647201210.1038/bjc.2012.13122498643
|
14.
|
P RieskeJK BartkowiakAM SzadowskaB
OlborskiB Harezga-BalM Debiec-RychterA comparative study of
P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity
in soft-tissue sarcomasJ Exp Clin Cancer
Res18403416199910606188
|
15.
|
AL KimY ZhuH ZhuResveratrol inhibits
proliferation of human epidermoid carcinoma A431 cells by
modulating MEK1 and Ap-1 signalling pathwaysExp
Dermatol15538546200610.1111/j.1600-0625.2006.00445.x16761963
|
16.
|
N KuwajerwalaE CifuentesS
GautamResveratrol induces prostate cancer cell entry into s phase
and inhibits DNA synthesisCancer Res6224882492200211980638
|
17.
|
S VyasY AsmeremDD De LeónResveratrol
regulates insulin-like growth factor-II in breast cancer
cellsEndocrinology14642244233200510.1210/en.2004-134416037384
|
18.
|
L GolkarXZ DingMB UjikiResveratrol
inhibits pancreatic cancer cell proliferation through
transcriptional induction of macrophage inhibitory cytokine-1J Surg
Res138163169200710.1016/j.jss.2006.05.037
|
19.
|
J Gora-TyborJZ BlonskiT RobakCirculating
vascular endothelial growth factor (VEGF) and its soluble receptors
in patients with chronic lymphocytic leukemiaEur Cytokine
Netw164146200515809205
|
20.
|
DJ HicklinLM EllisRole of the vascular
endothelial growth factor pathway in tumor growth and angiogenesisJ
Clin Oncol2310111027200510.1200/JCO.2005.06.08115585754
|